PRESS RELEASE published on 01/09/2024 at 17:30, 1 year 10 months ago Sordoni Construction Co. Announces It Has Gained a Project Executive Sordoni Construction Company is thrilled to announce the promotion of Dayton Pierce from Project Director to Project Executive. With 17 years of industry experience, Dayton has a comprehensive understanding of managing and overseeing various project components both on and off the field, including entitlements, preconstruction, procurement, cost management, scheduling, and safety. His promotion is a recognition of his hard work mentality, ability to mentor his teams, and his successful track record of completing over $125 million of projects. Dayton's wide range of project experience includes life sciences, residential, corporate, commercial, and industrial, making him a valuable asset to the company. Industry Experience Dayton Pierce Sordoni Construction Company Construction Management Project Executive
PRESS RELEASE published on 12/13/2023 at 17:00, 1 year 11 months ago Sordoni Golf Outing Raises $30,000 for Bergen County’s United Way
Published on 12/05/2025 at 02:35, 3 hours 27 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 2 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 57 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 2 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 11 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 47 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 52 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 2 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 17 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 18 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 1 minute ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
